Bicycle Therapeutics plc (BCYC)

SEC filing

Bicycle Therapeutics plc

BCYC · CIK 1761612

4/A · Oct 7, 2026 · Chief Operating Officer Perry Jennifer Scott sold 356 shares at $3.76/share ($1,339)

4/A

Chief Operating Officer Perry Jennifer Scott sold 356 shares at $3.76/share ($1,339)

xslF345X06/form4a-10072026_101043.xml

xslF345X06/form4a-10072026_101043.xmlSEC.gov

Graphics and non-inline formats (not embedded below).